Related Experiment Video
Updated: Feb 18, 2026

Luminophore Formation in Various Conformations of Bovine Serum Albumin by Binding of GoldIII
Published on: August 31, 2018
Structure and Affinity of Cu(I) Bound to Human Serum Albumin
Madison Sendzik1, M Jake Pushie2, Ewelina Stefaniak1,3
1Department of Chemistry and Physics, Saint Mary's College , Notre Dame, Indiana 46556, United States.
Insights
Human serum albumin (HSA) binds copper(I) (Cu(I)) with high affinity, challenging the assumption that only copper(II) interacts with HSA. This unappreciated Cu(I) interaction may be significant in human extracellular fluids.
Area of Science:
- Biochemistry
- Metalloprotein Chemistry
- Neuroscience
Background:
- Human serum albumin (HSA) is the primary copper (Cu) carrier in blood and cerebrospinal fluid.
- Previous research focused on Cu(II)-HSA interactions, assuming Cu(I) binding was negligible.
- HSA's role in Cu(I) binding and its coordination chemistry remained largely uninvestigated.
Purpose of the Study:
- To characterize the affinity of HSA for Cu(I).
- To determine the coordination structure of Cu(I) bound to HSA.
- To assess the significance of Cu(I)-HSA interactions in biological systems.
Main Methods:
- Solution competition experiments to determine apparent affinity.
- X-ray absorption spectroscopy (XAS) to elucidate coordination structure.
- In silico modeling to complement experimental findings.
Main Results:
- HSA exhibits a high apparent conditional affinity for Cu(I) (KCu(I):HSA = 1014.0) at pH 7.4.
- Cu(I) binds to HSA in a digonal coordination, similar to histidine coordination in amyloid beta and prion proteins.
- This binding occurs despite the common assumption of Cu(II) as the primary species interacting with HSA.
Conclusions:
- HSA binds Cu(I) with a surprisingly high affinity, suggesting a significant, overlooked role in copper transport.
- The characterized Cu(I) coordination structure provides insights into metalloprotein interactions.
- Cu(I)-HSA interactions warrant further investigation for their implications in human physiology and disease.
Abstract:
Human serum albumin (HSA) is a major Cu carrier in human blood and in cerebrospinal fluid. A major assumption is that Cu bound to HSA is in the Cu(II) oxidation state; thus, interactions between HSA and Cu(II) have been intensely investigated for over four decades. HSA has been reported previously to support the reduction of Cu(II) to the Cu(I) oxidation state in the presence of the weak reductant, ascorbate; however, the interactions between HSA and Cu(I) have not been explicitly investigated. Here, we characterize both the apparent affinity of HSA for Cu(I) using solution competition experiments and the coordination structure of Cu(I) bound to HSA using X-ray absorption spectroscopy and in silico modeling. We find that HSA binds to Cu(I) at pH 7.4 with an apparent conditional affinity of KCu(I):HSA = 1014.0 using digonal coordination in a structure that is similar to the bis-His coordination modes characterized for amyloid beta (Aβ) and the prion protein. This high affinity and familiar Cu(I) coordination structure suggests that Cu(I) interaction with HSA in human extracellular fluids is unappreciated in the current scientific literature.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
11:38Quantifying the Binding Interactions Between CuII and Peptide Residues in the Presence and Absence of Chromophores
Published on: April 5, 2022
Related Concept Videos
Drug Distribution: Plasma Protein Binding
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
Formation of Complex Ions
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Extraction: Advanced Methods
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...